FDA Rejection of Gene Therapy Overturned After Trump Official Ousted

A previously rejected gene therapy treatment has been approved after the departure of FDA official Vinay Prasad, who had blocked the approval. This reversal highlights the significant impact of political leadership changes on medical innovation and patient access to life-saving treatments. The decision underscores the importance of regulatory independence and the potential for bureaucratic delays to hinder scientific progress.